
World Market for AI in Medical Imaging
Description
Marketstrat's "World Market for AI in Medical Imaging" 2025-2032 quantifies and explains the fastest-growing slice of diagnostic imaging: software algorithms that detect, triage, quantify or automate findings across CT, MRI, X-ray/DR, Ultrasound and PET/Nuclear studies. Global market reached US $ 2.7 billion in 2023 and is projected to climb to US $ 28.4 billion by 2032—a 29.9 % CAGR driven by enterprise “AI-store” contracts, payer reimbursement codes (NTAP, CADx CPT, Chinese subsidies) and rising scan volumes amid radiologist shortages. North America remains the single largest dollar contributor, but APAC overtakes Europe in growth rate after 2027. CT and MRI account for >60 % of spend today, while Oncology AI overtakes Neurology by 2028. Seven Marketstrat proprietary frameworks—M³, TEM, ARC, GTM Growth-Maturity, Platform-Leverage, Ecosystem Collaboration, and Solution Adoption & Growth—translate thousands of datapoints into four-quadrant visuals that flag where evidence, technical readiness and go-to-market execution converge. Volume One provides the macro view, market analyses + forecasts, strategic frameworks, and Volume Two provides a vendor-level lens on 120 companies.
Two-volume package—Volume 1 “Market Analysis & Forecasts” (380 pages) and Volume 2 “Company Briefs” (510 pages).
Segmentation depth: Forecasts cut by five imaging modalities, seven clinical application areas, five geographic regions (twelve individual countries plus regional clusters), three revenue streams, five end-use or buyer segments / organizations, six AI technology categories.
Time frame: 2023–24 actuals with 2025-2032 outlook;
Key proprietary analytical frameworks: M³ Matrix (size vs CAGR hotspots), TEM Map (technology maturity), ARC Index (approvals + reimbursement + clinical evidence), GTM Growth-Maturity Quadrant (vendor trajectory), Platform-Leverage Strip (ARR stickiness), Ecosystem Collaboration, and Solution Adoption & Growth Matrix (suite depth vs scaling velocity).
Company Briefs: 120 Company profiles with frameworks & proprietary tools (Platform Leverage Strip, Growth & Maturity Heatmap, Attach-Rate Model, Reg-P Matrix. These briefs are decision tools. Numbers are directional, normalized for comparability, and best read alongside the underpinning sensitivity tables. Marketstrat Insights highlight levers—attach rate, modality expansion, and regulatory cadence. Use the Growth & Maturity Heatmap to gauge trajectory; deploy the Marketstrat Insight scenarios to stress test your own assumptions; consult the Watch Items to track each company’s execution risk.
Intended users: OEM and pure-play AI SW comapanies, investors sizing attach-rate upside, hospitals vetting vendor evidence before purchase, and regulators monitoring SaMD clearance velocity.
Please note - Volume -II - 120+ Company Briefs available with purchase. Please contact us to request your copy.
Two-volume package—Volume 1 “Market Analysis & Forecasts” (380 pages) and Volume 2 “Company Briefs” (510 pages).
Segmentation depth: Forecasts cut by five imaging modalities, seven clinical application areas, five geographic regions (twelve individual countries plus regional clusters), three revenue streams, five end-use or buyer segments / organizations, six AI technology categories.
Time frame: 2023–24 actuals with 2025-2032 outlook;
Key proprietary analytical frameworks: M³ Matrix (size vs CAGR hotspots), TEM Map (technology maturity), ARC Index (approvals + reimbursement + clinical evidence), GTM Growth-Maturity Quadrant (vendor trajectory), Platform-Leverage Strip (ARR stickiness), Ecosystem Collaboration, and Solution Adoption & Growth Matrix (suite depth vs scaling velocity).
Company Briefs: 120 Company profiles with frameworks & proprietary tools (Platform Leverage Strip, Growth & Maturity Heatmap, Attach-Rate Model, Reg-P Matrix. These briefs are decision tools. Numbers are directional, normalized for comparability, and best read alongside the underpinning sensitivity tables. Marketstrat Insights highlight levers—attach rate, modality expansion, and regulatory cadence. Use the Growth & Maturity Heatmap to gauge trajectory; deploy the Marketstrat Insight scenarios to stress test your own assumptions; consult the Watch Items to track each company’s execution risk.
Intended users: OEM and pure-play AI SW comapanies, investors sizing attach-rate upside, hospitals vetting vendor evidence before purchase, and regulators monitoring SaMD clearance velocity.
Please note - Volume -II - 120+ Company Briefs available with purchase. Please contact us to request your copy.
Table of Contents
890 Pages
- SECTION 1 – EXECUTIVE SUMMARY
- Why This Market Matters — the 25-second Read
- Global Growth at a Glance
- Five Strategy Headlines to Internalize
- Where Growth Concentrates – Modality & Clinical Slices
- Regional Pulse – Inflection Points & Watchouts
- Competitive Heat - the Five Moves to Track
- Three-year KPI Outlook (2024 → 2027)
- Six Board-level Actions for the Next 12 Months
- Methodology Summary
- SECTION 2 – RESEARCH METHODOLOGY
- About the Report
- Scope & Segmentation
- Marketstrat’s “Insights → Action” Approach
- Dual-Lens Architecture
- Top-Down Market Funnel
- Bottom-up Attach Rate Flow
- Evidence Confidence – Density vs Reliability
- Framework Stack – Turning Insight into Action
- Quality Assurance Loop
- Limitations & Mitigations
- Company Briefs Methodology (Vol Two)
- SECTION 3 – STRATEGIC MARKET ANALYSIS & FRAMEWORKS
- Why Read This Chapter?
- Outlook (2025–2030)
- Recommendations by Stakeholder Type
- Section Introduction
- Global Market & Procedure Volumes: Contextual Overview
- Imaging Procedure Volumes
- Core Reference — Annual Procedure Volumes
- Market Drivers and Restraints
- Top Market Drivers (Ranked)
- Top Market Restraints (Ranked)
- World Market Forecast by Region (2023-2032)
- Regional Growth Pattern
- Strategic Implications for Vendors
- Markintel M^3 Matrix (Market Momentum Matrix)
- Portfolio Recommendations
- Market Size vs. 2024-32 CAGR
- Market Momentum by Modality
- Market Momentum by Clinical Segment
- Market Phases
- Market Sensitivity — Tariffs & FX (2024-26)
- Markintel Technology Evolution Matrix (TEM)
- TEM by Geographic Region
- TEM by Imaging Modality
- TEM by Clinical Application
- Markintel TEM Scoring Framework – Methodology Snapshot
- Markintel TEM by Region (2025) – Numeric Scorecard
- Markintel TDIT (Technology Diffusion and Impact Timeline)
- TDIT Stage Definitions & Horizon
- TDIT Quantitative Impact Tags
- Key Inflection Drivers
- Potential Roadblocks
- Marketstrat Actionable Insights
- Markintel Solution Adoption & Growth Matrix - Worldwide
- Immediate Strategic Recommendations
- Quantification Guide
- Illustrative Segment Scores
- Quadrant Explanations & Global AI Solution Examples
- Marktintel ARC Index (Approvals, Reimbursement, Clinical Validation)
- Markintel ARC Index by Use Case
- Rationale for ARC Index Score by Use Case
- Markintel ARC Index Score by Clinical Area
- Oncology and Sub-Areas
- Neurology and Sub-Areas
- Cardiology and Sub-Areas
- Respiratory/Pulmonary and Sub-Areas
- Orthopedics and Sub-Areas
- Regulatory and Compliance Trends
- FDA Approvals: Key Details
- Global Regulatory Landscape
- Potential Shifts
- FDA Clearances & Emerging Regulatory Landscapes
- Regulatory & Reimbursement Snapshot – Update to Apr 2025
- FDA Imaging-AI Clearances Heatmap, 2018 – 2025 YTD
- Reimbursement Timeline Snapshot
- FDA Clearances by Modality (cumulative Apr 2025)
- Reimbursement Timeline Detail
- Markintel GTM Growth Maturity Matrix – World Market
- Competitive Dataset – World Market for AI Imaging
- Key Takeaways
- Growth & Maturity Highlights (selected)
- Competitive Landscape and Clusters
- 1. Imaging OEM AI Suites
- 2. AI-first Software Vendors
- 3. Cloud & Platform Enablers
- 4. Regional Champions
- 5. Specialist Niches
- SECTION 4 – WORLD MARKET ANALYSIS & FORECAST
- Section Overview
- Why Read This Chapter?
- World Market for AI in Medical Imaging – Volume One
- © Marketstrat. All rights reserved. Page 7 | Markintel Horizon Report Series
- Marketstrat Thesis
- Regional Growth Picture
- World Market Forecast by Region (2023-2032, $ Mill)
- Strategic Takeaways
- Big-5 Regions CAGR Waterfall
- World Market Analysis by Clinical Area
- Clinical Area Summary
- Global Forecast by Clinical Area (2023-2032, USD Mill)
- What the Numbers Mean for Strategists
- Caveats & watch-points
- Clinical Area Definitions
- Oncology Imaging AI Market Worldwide
- Market Forecast by Region – Oncology Imaging AI (2023-2032, USD Mill)
- Oncology Imaging AI: From Niche App to Enterprise Platform
- Regional Growth Snapshot (2023 → 2032)
- Strategic Implications for Vendors
- Market Momentum & Outlook
- Markintel GTM Growth Maturity Framework – Oncology AI Worldwide
- Competitive Dataset - Oncology AI Imaging
- Competitive Context – Oncology AI
- Strategic Takeaways – Oncology AI
- Growth & Maturity Highlights (All Vendors)
- Fast-Mover M&A Targets (Oncology AI)
- Regulatory Velocity – New FDA Clearances Oncology Imaging AI
- Modality-Reach Heatmap – Oncology Imaging AI 2024
- Procedure Volumes
- AI Applications & Adoption Trajectories
- Cardiology Imaging AI Market Worldwide
- Market Forecast by Region (2023-2032, USD Mill)
- Cardiology AI – Why Adoption is Breaking Out
- Regional Growth Snapshot
- Strategic Implications
- Markintel GTM Growth Maturity Framework – Cardiology Imaging AI Worldwide
- Competitive Dataset - Cardiology AI-Imaging
- Competitive Context – Cardiology AI
- Strategic Takeaways
- Growth & Maturity Highlights – Cardiology Imaging AI
- M&A Watch -- Fast-Moving Rising Stars
- Regulatory Velocity – New Cardiology AI Imaging Clearances (Mar 2024 to June 2025)
- Modality-Reach Heatmap – Cardiology AI 2024
- Procedure Volumes
- AI Applications & Adoption
- Future Directions
- Neurology Imaging AI Market Worldwide
- Market Forecast by Region (2023-2032, USD Mill)
- Why Adoption is Moving Beyond Stroke Triage
- Regional Growth Snapshot
- Strategic Implications
- Markintel GTM Growth Maturity Framework – Neurology Imaging AI Worldwide
- Competitive Dataset - Neurology AI-Imaging
- Competitive Context — Neurology AI
- Strategic Takeaways
- Growth and Maturity Highlights – Neurology AI Imaging
- Fast-Mover M&A Watch-List — Neurology AI
- Regulatory Velocity – New Neuro-AI Clearances – Neurology AI Imaging (Mar ’24 – Jun ’25)
- Modality Reach Heat-Map – Neurology AI 2024
- Procedure Volumes – Neurology Imaging AI
- AI Use-Cases
- Market Evolution
- Respiratory Imaging AI Market Worldwide
- Market Forecasts by Region (2023 – 2032, USD Mill)
- What Ignited the 2024 Breakout
- Regional Growth Snapshot
- Strategic Implications
- Markintel GTM Growth Maturity Framework – Respiratory Imaging AI – World
- Competitive Dataset – Respiratory AI Imaging
- Competitive Context — Respiratory AI
- Strategic Takeaways
- Growth and Maturity Highlights
- Fast-Mover M&A Watchlist
- Regulatory Velocity – New Respiratory-AI Clearances (Mar ’24 – Jun ’25)
- Modality Reach Heat-Map – Respiratory Imaging AI Worldwide - 2024
- Orthopedic/MSK Imaging AI Market Worldwide
- Market Forecasts by Region (2023 – 2032, USD Mill)
- What is Driving Acceleration
- Regional Growth Snapshot
- Strategic Implications
- Markintel GTM Growth Maturity Framework – Orthopedic/MSK Imaging AI - World
- Competitive Dataset – Orthopedic Imaging AI
- Competitive Context — MSK (Orthopedic) AI
- Strategic Takeaways
- Growth and Maturity Highlights
- Fast-Mover M&A Watchlist
- Procedure Volumes
- AI Adoption & Key Applications
- Regulatory Velocity – Orthopedic (MSK) Imaging AI Worldwide - (Mar ’24 – Jun ’25)
- Use Cases
- AI Solutions
- Modality Reach Heat-Map – Orthopedic (MSK) AI
- Other Clinical Areas Imaging AI Market Worldwide
- Market Forecasts by Region (2023 – 2032, USD Mill)
- Segment Overview & Characteristics
- Regional Snapshot
- Strategic Takeaways
- Revenue Breakdown — “Other” Clinical Areas Worldwide (2024)
- Sub-Areas, Use Cases, Vendors
- Reimbursement Readiness Heatmap
- Depth vs Breadth Snapshot
- Regulatory Velocity – Other Clinical Areas Imaging AI (Mar ’24 – Jun ’25)
- Strategic Takeaways
- M&A Watchlist
- World Market Analysis by Imaging Modality
- Modality Outlook: Where AI Value Pools Shift Through 2032
- Highlights
- Global Forecast by Modality (2023-2032, USD Mill)
- Market Math & Diffusion Pattern
- Strategic Takeaways for Vendors
- Modality Definitions
- CT Modality Imaging AI Market Worldwide
- Market Forecast by Region – CT Imaging AI (2023 – 2032, USD Mill)
- Regional mix in 2032
- Adoption Accelerators
- Strategic implications for vendors
- Markintel GTM Growth and Maturity Matrix – CT Imaging AI – World
- Competitive Dataset - CT AI-Imaging
- Growth and Maturity Highlights - CT AI-Imaging Companies
- Competitive Context – CT modality AI
- Strategic Takeaways for 2024-2027
- M&A Watchlist – Global CT AI
- Regulatory Velocity – CT-Specific Clearances
- Attach-Rate by Region (CT only, 2024)
- Revenue Split (Factory vs Retrofit) by Region – CT
- Procedure Volumes & Applications
- MRI Modality Imaging AI Market Worldwide
- Market Forecast by Region – MRI Imaging AI (2023 – 2032, USD Mill)
- Regional Mix in 2032
- Adoption Accelerators
- Strategic Implications
- Markintel GTM Growth and Maturity Matrix – MRI Imaging AI – World
- Competitive Dataset - MRI AI-Imaging
- Growth and Maturity Highlights - MRI AI-Imaging Companies
- Competitive Context – MRI AI Modality
- Strategic Takeaways for 2024 – 2027
- M&A Watchlist – Global MRI AI
- Regulatory Velocity (MRI-AI Clearances)
- Attach-Rate by Region - MRI
- Factory vs Retrofit Revenue Split (MRI, 2024)
- Procedure Volumes & Applications
- X-ray Modality Imaging AI Market Worldwide
- Market Forecast by Region – X-ray Imaging AI (2023-2032, USD Mill)
- Regional Split - 2032
- Adoption Accelerators
- Strategic implications
- Markintel GTM Growth and Maturity Matrix – X-ray Imaging AI – World
- Competitive Dataset
- Growth and Maturity Highlights - X-ray AI-Imaging Companies
- Competitive Context — X-ray Modality AI
- Strategic Takeaways 2024-27
- M&A Watchlist - Global X-ray-AI
- Regulatory Velocity – X-ray AI
- Attach-Rate by Region (X-ray, 2024)
- Factory vs Retrofit Revenue Split (X-ray, 2024)
- Market & Procedure Volumes
- Ultrasound Modality Imaging AI Market Worldwide
- Market Forecast by Region – Ultrasound Imaging AI (2023-2032, USD Mill)
- Regional Split – 2032
- Adoption Accelerators
- Strategic Market Implications
- Markintel GTM Growth and Maturity Matrix – Ultrasound AI - World
- Competitive Dataset – FY-2024 Ultrasound AI-Imaging (Worldwide)
- Growth & Maturity Highlights - Ultrasound AI
- Competitive Context – Ultrasound AI
- Strategic Takeaways 2024-2027
- AI M&A Watchlist - Global Ultrasound
- Regulatory Velocity – Ultrasound AI (Mar-23 → Mar-24)
- Attach-Rate by Region (Ultrasound)
- Factory vs Retrofit Revenue Split (Ultrasound)
- Market & Procedure Volumes
- Nuclear/PET Modality Imaging AI Market Worldwide
- Market Forecast by Region (2023-2032, USD Mill)
- Regional Split – 2032
- Adoption Accelerators
- Strategic Market Implications
- Markintel GTM Growth and Maturity Matrix – Nuclear/PET imaging AI – World
- Competitive Dataset - Nuclear/PET AI-Imaging
- Growth & Maturity Highlights – Nuclear / PET AI
- Competitive Context – Nuclear/PET AI
- Strategic Takeaways
- M&A Watchlist – Nuclear/PET Imaging
- Market & Procedure Volumes
- World Market Analysis by Revenue Stream
- Forecast by Revenue Stream (2023-2032, USD Mill)
- Revenue-Stream Dynamics
- Regional Color
- Strategic Takeaways
- Revenue Stream Segments
- World Market Analysis by Clinical Application
- Forecast by Clinical Application (2023-2032, USD Mill)
- Functional Value Pools
- Regional Color
- Strategic Takeaways
- Use-Case/Workflow Segmentation
- AI Clinical Solutions
- World Market Analysis by End-Use Organization
- Forecast by End-Use Organization (2023-2032, $US Mill)
- Buyer Mix Shift
- Regional Color
- Strategic Implications
- End-Use Org Definitions
- World Market Analysis by AI Technology
- Forecast by AI Technology (2023-2032, $US Mill)
- Technology Mix
- Regional Color
- Strategic Takeaways
- AI Technology Definitions and Applications
- Deep Learning
- Computer Vision (Classical)
- Machine Learning (Traditional)
- Natural Language Processing (NLP)
- Robotics
- Expert Systems
- Summary Comparison of AI Technologies
- Key Takeaways
- SECTION 5 – REGIONAL MARKET ANALYSIS & FORECAST
- What’s in This Section?
- Why Read This Section?
- 1. NORTH AMERICAN MARKET
- Market Summary
- Market Size & Drivers
- Latest Trends
- Strategic Outlook
- Competitive Environment
- New Focus Areas
- North American Market Estimates & Forecasts (2023-2032)
- AI Imaging Market by Country - North America
- What’s Driving the Numbers
- Implications
- Markintel GTM Growth and Maturity Matrix – North America
- Competitive Dataset – North America
- Competitive Context — North America AI-Imaging 2024
- Strategic Takeaways
- Growth & Maturity Highlights – North America
- M&A Watchlist — North America Rising Stars
- Regulatory Velocity – North America
- Source: Marketstrat Analysis of Public Data
- OEM AI Attach-Rate by Modality
- Source: Marketstrat Analysis
- Attach Rate Trends – North America
- Factory vs Retrofit – North America
- 2. UNITED STATES MARKET
- Market Summary – United States
- Key Market Dynamics
- Strategic Takeaways
- Top 3 Recommendations
- Market Overview – United States
- Demographics & Epidemiology
- Macro-economics & Health Spending
- Imaging Volume & Installed Base
- Regulatory & Reimbursement Snapshot
- Healthcare Delivery & Practice Patterns
- AI Market Dynamics (Imaging)
- Competitive Landscape
- Takeaways for Vendors
- US Market by Clinical Area
- Forecast by Clinical Area (2023-2032, USD Mill)
- U.S. AI-Imaging Outlook by Clinical Area (2023 → 2032)
- Key Dynamics to Watch
- Implications for Vendors
- US Market by Imaging Modality
- Forecast by Modality (2023-2032, USD Mill)
- U.S. Modality Outlook: Who Grows, Who Overtakes
- Key Takeaways
- US Market by Revenue Stream
- Forecast by Revenue Stream (2023-2032, USD Mill)
- U.S. Revenue Stream Shift: From Capital Boxes to Recurring Bytes
- What’s Driving the Mix Change
- Implications for Vendors
- US Market by Clinical Application
- Forecast by Clinical Application (2023-2032, USD Mill)
- Outlook by Clinical Application
- Highlights
- Implications
- US Market by End-Use Organization
- Forecast by End-Use Organization (2023-2032, USD Mill)
- Who Buys AI—and How That Mix Shifts Through 2032
- What’s Behind the Shift
- Strategic Implications for Vendors
- US Market by AI Technology
- Forecast by AI Technology (2023-2032, USD Mill)
- Outlook by Core Technology (2023-2032)
- Markintel Growth Maturity Matrix – US & Canada
- Competitive Dataset – United States
- Competitive Context — U.S./North America
- What to Watch Next
- Markintel Solution Adoption & Growth Matrix – US & Canada
- Scorecard — Solution Adoption & Growth Matrix (U.S. & Canada)
- Strategic Implications for Stakeholders
- Markintel Ecosystem Collaboration Matrix – US & Canada
- Who to Partner with and How Deep?
- What Succeess Looks Like in Each Quadrant
- Stratregic Guidance
- GTM at a Glance – United States
- Channel & Pricing Matrix
- GTM Readiness Radar - US
- Customer Tier Potential - US
- GTM Timeline (2025–2028) - US
- Fast Strategic Cues (2025)
- Regulatory x Funding Heatmap – US
- Adjacency-Opportunity Radar – US
- Whitespace Partner-Fit Matrix – US
- 3. CANADIAN MARKET
- Market Summary: Canada
- Key Market Dynamics
- Strategic Takeaways
- Top 3 Recommendations
- Market Overview - Canada
- Demographics & Epidemiology
- Imaging Supply & Utilization
- Health System & Practice Patterns
- Regulatory & Reimbursement
- AI-Imaging Market Dynamics
- Competitive Snapshot
- Key Implications
- Canadian Market by Clinical Area
- Forecast by Clinical Area (2023-2032, USD Mill)
- Outlook by Clinical Area
- Key Dynamics to Watch
- Implications for Vendors
- Canadian Market by Imaging Modality
- Forecast by Imaging Modality (2023-2032, USD Mill)
- Outlook by Modality
- Key Dynamics to Watch (2025-27)
- Implications for Vendors
- Canadian Market by Revenue Stream
- Forecast by Revenue Stream (2023-2032, USD Mill)
- What’s Driving Each Revenue Stream
- Key Dynamics to Watch
- Implications for Vendors
- Canadian Market by Clinical Application
- Forecast by Clinical Application (2023-2032, USD Mill)
- Outlook & Drivers by Application
- Key Market Dynamics to 2027
- Implications for Vendors and Providers
- Canadian Market by End-Use Organization
- Forecast by End-Use Organization (2023-2032, USD Mill)
- Outlook 2025-2032
- Key Drivers by Segment
- Implications for Vendors
- Strategic Takeaways
- Canadian Market by AI Technology
- Forecast by AI Technology (2023-2032, USD Mill)
- Highlights by Technology
- Key Dynamics to Watch (2025-27)
- Implications for Vendors & Providers
- GTM at a Glance - Canada
- GTM Readiness Radar - Canada
- Tiered Customer Landscape
- Channel & Pricing Matrix
- GTM Timeline (Canada)
- Fast Cues for 2025 Stakeholders
- 4. EUROPEAN MARKET
- Market Overview & Analysis
- Market Snapshot
- Structural Demand Signals
- Regulatory & Funding Landscape (2024-2028)
- Market Segmentation 2032 (value share)
- Competitive Heat Map (2024-26)
- Execution Playbook (2024-2027)
- Action-Oriented Recommendations
- European Market Estimates and Forecasts by Country (2023-2032, USD Mill)
- Five Forces Shaping Adoption
- Country Archetypes & What Sells
- Near-term Adoption Runway (2024-27)
- Strategic Implications
- Regulatory Velocity by Company – Europe
- Markintel Growth Maturity Matrix – Europe
- Landscape Snapshot
- Why the Quadrant Looks the Way it Does
- Key Competitive Dynamics
- Strategic Takeaways
- Bottom Line
- M&A Watchlist – Europe
- Competitive Dataset – Europe
- Growth & Maturity Highlights – Europe
- Markintel Ecosystem Collaboration Matrix (ECM) – Europe
- Quadrant Commentary & European Illustrations
- Action Checklist
- Markintel Solution Adoption & Growth Matrix – Europe
- Quadrant Deep Dive
- What Moves a Solution from One Box to the Next?
- Strategic Guidance
- AI Attach Rate - Europe
- OEM AI Attach Rate
- Attach Rate Trends – Europe
- AI Revenue Split – Factory vs Retrofit Attach -- Europe
- GTM at a Glance – Europe
- Channel & Pricing Matrix (2025-2028)
- GTM Readiness Radar — Europe
- Tiered Customer Landscape (2032 View)
- GTM Timeline (2025 → 2028) - Europe
- Adjacency Opportunity Radar (2026+) – Europe
- Regulatory x Funding Heatmap – Europe
- AI Imaging Whitespace Matrix – Europe
- Fast Strategic Cues (2025 playbook)
- 5. GERMAN MARKET
- Market Overview - Germany
- Macro & Epidemiology
- Health-system & Funding Landscape
- Regulatory & Evidence Pathway
- Competitive Landscape
- Strategic Takeaways & Recommendations
- German Market by Clinical Area
- Forecast by Clinical Area (2023-2032, USD Mill)
- Primary Growth Catalysts
- Strategic Messages for Stakeholders
- Key Takeaways
- German Market by Modality (2023-2032, USD Million)
- Forecast by Modality (2023-2032, USD Mill)
- Key Inflection by Modality
- What’s Driving Each Modality
- Strategic Implications
- German Market by Revenue Stream (2023-2032, USD Million)
- Forecast by Revenue Stream (2023-2032, USD Mill)
- Revenue Streams and Drivers
- Key Dynamics by Stream
- Strategic Guidance
- German Market by Clinical Application (2023-2032, USD Million)
- Forecast by Clinical Application (2023-2032, USD Mill)
- What is Driving Each Bucket
- Strategic Messages
- Action Playbook
- German Market by End-Use Organization (2023-2032, USD Million)
- Forecast by End-Use Organization (2023-2032, USD Mill)
- Segments Review
- Strategic Implications
- German Market by AI Technology (2023-2032, USD Million)
- Forecast by AI Technology (2023-2032, USD Mill)
- Germany – AI Imaging Market by Core Technology
- Why Deep Learning Keeps the Lion’s Share
- Break-out Growth Themes
- Strategic Playbook
- GTM at-a-Glance
- Channel x Pricing Matrix
- GTM Readiness Radar — Germany
- Tiered Customer Landscape
- GTM Timeline - Germany
- Fast Strategic Cues
- 6. FRENCH MARKET
- Market Summary: France
- Top-line Snapshot – France
- Key Market Dynamics
- Strategic Takeaways
- Top 3 Recommendations
- French Market Speed scan - Market Analysis (2024-2032)
- French Market Estimates and Forecasts (2023-2032)
- French Market by Clinical Area (2023-2032)
- French Market by Modality (2023-2032)
- French Market by Revenue Stream (2023-2032)
- French Market by Clinical Application (2023-2032)
- French Market by End-Use Organization (2023-2032)
- French Market by AI Technology (2023-2032)
- Quick Strategic Cues – France GTM
- GTM at a Glance - France
- Channel x Pricing Matrix
- GTM Readiness Radar — What Counts Most in France
- GTM Timeline (2024-30) - France
- Spend Potential by Customer Tier – France
- 7. UNITED KINGDOM MARKET
- Market Overview - United Kingdom
- UK Market Speed Scan
- UK Market Estimates and Forecasts (2023-2032)
- UK Market by Clinical Area (2023-2032)
- UK Market by Modality (2023-2032)
- UK Market by Revenue Stream (2023-2032)
- UK Market by Clinical Application (2023-2032)
- UK Market by End-Use Organization (2023-2032)
- UK Market by AI Technology (2023-2032)
- GTM at a Glance – UK
- Channel x Pricing Matrix
- GTM Readiness Radar – UK
- Fast Strategic Cues
- Tiered Customer Landscape
- GTM Timeline (2024-29) - UK
- 8. ITALIAN MARKET
- Market Overview & Summary: Italy
- What Makes Italy Unique in the EU Context
- Strategic Takeaways
- Italian Market Estimates & Forecasts (2023-2032)
- Italian Market by Clinical Area (2023-2032)
- Italian by Modality (2023-2032)
- Italian Market by Revenue Stream (2023-2032)
- Italian Market by Clinical Application (2023-2032)
- Italian Market by End-Use Organization (2023-2032)
- Italian Market by AI Technology (2023-2032)
- GTM at a Glance – Italy
- 1. Channel × Pricing Matrix
- 2. Tiered Customer Landscape & Spend Potential (2032)
- 3. GTM Readiness Radar - Italy
- 4. GTM Timeline (2024-29) - Italy
- 5. Fast Strategic Cues
- 9. SPANISH MARKET
- Market Overview & Summary - Spain
- Strategic Takeaways
- Spanish Market Estimates and Forecasts (2023-2032)
- Spanish Market by Clinical Area (2023-2032)
- Spanish Market by Modality (2023-2032)
- Spanish Market by Clinical Application (2023-2032)
- Spanish Market by Revenue Stream (2023-2032)
- Spanish Market by End-Use Organization (2023-2032)
- Spanish Market by AI Technology (2023-2032)
- GTM at a Glance – Spain
- GTM Readiness Radar – Spain
- Channel x Pricing Matrix
- Tiered Customer Landscape – Spain
- GTM Timeline – Spain
- 10. REST OF EUROPE (ROE) MARKET
- Market Overview: Rest of Europe (ROE)
- Strategic Takeaways
- Rest of European Market for AI in Medical Imaging (2023-2032)
- Rest of European Market by Clinical Area (2023-2032)
- Rest of European Market by Modality (2023-2032)
- Rest of European Market by Revenue Stream (2023-2032)
- Rest of European Market by Clinical Application (2023-2032)
- Rest of European Market by End-Use Organization (2023-2032)
- Rest of European Market by AI Technology (2023-2032)
- GTM at a Glance – Rest of Europe (ROE)
- GTM Readiness Radar – ROE
- Tiered Customer Landscape - ROE
- GTM Timeline - ROE
- Channel × Pricing Matrix
- Adjacency-Opportunity Matrix (2026-2030)
- Country-Cluster Framework & Strategic Playbook
- White-Space Partnership Matrix
- Regulatory Funding Heatmap (ROE Clusters)
- Fast Strategic Cues
- 11. ASIA-PACIFIC (APAC) MARKET
- Size, Trajectory & Strategic Importance
- Demand Drivers & Headwinds
- Competitive & Partnership Landscape
- Strategic Clustering & Go-to-Market Nuances
- Strategic Recommendations
- AI Imaging Market by Country – APAC
- Markintel GTM Growth and Maturity Matrix – APAC
- Competitive Data Set – APAC
- Numbers-in-Context – APAC
- Strategic Takeaways – APAC
- Growth & Maturity Highlights – APAC
- M&A Watchlist – APAC
- Regulatory Velocity - APAC
- OEM AI Attach Rate – APAC
- Attach‐Rate Trends – APAC
- GTM at a Glance – APAC
- GTM Readiness Radar – APAC
- Tiered Customer Landscape – APAC
- GTM Timeline – APAC
- Adjacency Opportunity Matrix - APAC
- Country-Cluster Framework - APAC
- White Space Partner Framework – APAC
- Regulatory Funding Heatmap – APAC
- Channel x Pricing Matrix – APAC
- Fast Strategic Cues – APAC
- 12. CHINESE MARKET
- China – Market Overview & Strategic Summary (2023‑2032)
- Strategic Takeaways
- Chinese Market Forecasts (2023-2032)
- Chinese Market by Clinical Area (2023-2032)
- Chinese Market by Modality (2023-2032)
- Chinese Market by Revenue Stream (2023-2032)
- Chinese Market by Clinical Application (2023-2032)
- Chinese Market by End-Use Organization (2023-2032)
- Chinese Market by AI Technology (2023-2032)
- Markintel Growth Maturity Matrix – China AI in Medical Imaging
- Executive Commentary
- Cross-Quadrant Insights & Tactical Guidance
- Priority Recommendations (next 18 months)
- Competitive Dataset – China
- Markintel Ecosystem Collaboration Matrix – China
- Decoding the 2 × 2 and Turning it into Action
- Three Rules for Winning the Collaboration Game
- Quick-hit Actions for BD teams (Next Two Quarters)
- Markintel Solution Adoption and Growth Matrix – China
- Translating the Matrix into Action
- Execution Priorities by Function
- “First-100-Days” Checklist
- Metrics that Matter
- Operating Roadmap Takeaway
- GTM at a Glance – China
- GTM Readiness Radar – China
- Tiered Customer Landscape – China
- GTM Timeline – China
- Adjacency-Opportunity Radar – China
- Regulatory Funding Heatmap - China
- Channel × Pricing Matrix - China
- White Space Partnership Matrix - China
- 13. JAPANESE MARKET
- Market Overview & Strategic Summary: Japan
- Strategic Outlook
- Action Points
- Japanese Market Forecasts (2023-2032)
- Japanese Market by Clinical Area (2023-2032)
- Japanese Market by Modality (2023-2032)
- Japanese Market by Revenue Stream (2023-2032)
- Japanese Market by Clinical Application (2023-2032)
- Japanese Market by End-Use Organization (2023-2032)
- Japanese Market by AI Technology (2023-2032)
- Markintel Solution Adoption & Growth Matrix - Japan
- Turning the Matrix into an Operating Road-Map for Japan (2024-28)
- Markintel Ecosystem Collaboration Matrix – Japan
- Turning the Matrix into an Operating Roadmap
- Playbook Highlights by Quadrant
- Risk Checkpoints & Mitigations
- Go-to-Market (GTM) Playbook – Japan
- GTM Readiness Radar – Japan
- Tiered Customer Landscape – Japan
- GTM Timeline – Japan
- Adjacency Opportunity Radar – Japan
- Regulatory Funding Heatmap – Japan
- Channel x Pricing Matrix – Japan
- White Space Partnership Matrix – Japan
- Fast Strategic Cues
- 14. INDIAN MARKET
- Market Overview & Analysis
- Executive Snapshot
- Market Mechanics
- Constraint Map
- Competitive Temperature (“5 P” quick lens)
- Actionable Opportunities (2024-26 Window)
- Go-Forward Recommendations (by player type)
- What Success Looks Like
- Indian Market Forecasts (2023-2032)
- Indian Market by Clinical Area (2023-2032)
- Indian Market by Modality (2023-2032)
- Indian Market by Revenue Stream (2023-2032)
- Indian Market by Clinical Application (2023-2032)
- Indian Market by End-Use Organization (2023-2032)
- Indian Market by AI Technology (2023-2032)
- Markintel Solution Adoption & Growth Matrix - India
- Solution Classes and Action Cues
- Strategic Interpretation & Operating Roadmap
- One-Page Operating Checklist
- Markintel Ecosystem Collaboration Matrix - India
- Operating Roadmap: Leveraging India’s Collaboration Matrix
- Strategic Sequencing (2024-27)
- Execution Tips
- Key Metrics to Track
- Competitive Landscape – India
- Key Competitive Insights
- Operating Roadmap
- GTM at a Glance – India
- GTM Readiness Radar – India
- Tiered Customer Landscape – India
- GTM Timeline – India
- Adjacency-Opportunity Radar – India
- Regulatory x Funding Heatmap – India
- White-Space Partnership Matrix
- Channel × Pricing Matrix
- Fast Strategic Cues (Do-This-First)
- 15. SOUTH KOREAN MARKET
- Market Summary: South Korea
- Key Market Dynamics
- Strategic Takeaways
- Top 3 Recommendations
- South Korean Market Forecasts (2023-2032)
- South Korean Market by Clinical Area (2023-2032)
- South Korean Market by Modality (2023-2032)
- South Korean Market by Revenue Stream (2023-2032)
- South Korean Market by Clinical Application (2023-2032)
- South Korean Market by End-Use Organization Type (2023-2032)
- South Korean Market by AI Technology (2023-2032)
- GTM at a Glance – South Korea
- Six-Pillar GTM Readiness Radar – South Korea
- Tiered Customer Landscape – South Korea
- Five-Step GTM Timeline – South Korea
- Adjacency-Opportunity Radar – South Korea
- Regulatory x Funding Heatmap – South Korea
- Whitespace Partnership Matrix – South Korea
- Channe × Pricing Matrix – Typical 2025 Deals
- Fast Strategic Cues
- 16. AUSTRALIAN MARKET
- Market Overview & Analysis
- Market Structure & Growth Drivers
- Segment Hotspots (Qualitative Sizing)
- Competitive Landscape
- Strategic Implications & GTM Priorities
- Action-Oriented Recommendations (Next 12 Months)
- Australian Market Forecasts (2023-2032)
- Australian Market by Clinical Area (2023-2032)
- Australian Market by Modality (2023-2032)
- Australian Market by Revenue Stream (2023-2032)
- Australian Market by Clinical Application (2023-2032)
- Australian Market by End-Use Organization (2023-2032)
- Australian Market by AI Technology (2023-2032)
- GTM at a Glance – Australia
- GTM Readiness Radar – Australia
- GTM Timeline – Australia
- Adjacency-Opportunity Radar – Australia
- Regulatory x Funding Heatmap
- 17. REST OF ASIA-PACIFIC (ROAPAC) MARKET
- Market Overview & Analysis
- Regional Clusters
- Market Dynamics ― What’s Shaping Buying Decisions
- Actionable Recommendations
- Quick-Hit Opportunities by Cluster
- What Success Looks Like
- Rest of Asia-Pacific Market Forecasts (2023-2032)
- Rest of Asia-Pacific (ROAPAC) Market by Clinical Area (2023-2032)
- Rest of Asia-Pacific (ROAPAC) Market by Modality (2023-2032)
- Rest of Asia-Pacific (ROAPAC) Market by Revenue Stream (2023-2032)
- Rest of Asia-Pacific (ROAPAC) Market by Clinical Application (2023-2032)
- Rest of Asia-Pacific (ROAPAC) Market by End-Use Organization (2023-2032)
- Rest of Asia-Pacific (ROAPAC) Market by AI Technology (2023-2032)
- GTM at a Glance – ROAPAC
- GTM Readiness Heatmap – ROAPAC Clusters
- Five-Step GTM Roll-Out Timeline (2024-2029) – Keyed to Clusters
- 18. LATIN AMERICAN (LATAM) MARKET
- Market Overview & Analysis: Latin America (LATAM)
- Market Summary
- Growth Driver Waterfall – LATAM
- Geo-Economic Clusters (for GTM focus)
- Segment Trends to 2032
- Regulatory Snapshot (big-5)
- Action-Oriented Recommendations
- LATAM Market Estimates and Forecasts
- LATAM Market by Clinical Area (2023-2032)
- LATAM Market by Modality (2023-2032)
- LATAM Market by Revenue Stream (2023-2032)
- LATAM Market by Clinical Application (2023-2032)
- LATAM Market by End-Use Organization (2023-2032)
- LATAM Market by AI Technology (2023-2032)
- Markintel Solution Adoption & Growth Matrix - LATAM
- Cross-Quadrant Operating Roadmap (2024-27)
- Markintel Ecosystem Collaboration Matrix – LATAM
- Operating Roadmap (90-Day Focus)
- GTM at-a-Glance – LATAM
- GTM Readiness Radar – LATAM
- GTM Timeline – LATAM
- LATAM Country Clusters Summary
- Cluster-Priority Heatmap
- Regulatory Velocity & Reimbursement Pulse - LATAM
- OEM AI Attach Rate – LATAM
- GTM Maturity Highlights by Company – LATAM
- 19. MIDDLE EAST & AFRICAN MARKET
- Market Overview & Analysis: Middle East & Africa (MEA)
- LATAM Snapshot
- Logical Clusters & Why They Matter
- Key Growth Catalysts
- Structural Barriers & Mitigation
- Actionable Recommendations by Vendor Type
- Sequencing Roadmap
- Executive Takeaways
- Middle East & Africa (MEA) – Market Estimates and Forecasts
- MEA Market by Clinical Area (2023-2032)
- MEA Market by Modality (2023-2032)
- MEA Market by Revenue Stream (2023-2032)
- MEA Market by Clinical Application (2023-2032)
- MEA Market by End-Use Organization (2023-2032)
- MEA Market by AI Technology (2023-2032)
- Markintel Solution Adoption & Growth Matrix – MEA
- Interpretation & Operating Roadmap
- Execution Checklist
- Markintel Ecosystem Collaboration Matrix – MEA
- Partnership Playbook
- Operating Roadmap & Key Execution Metrics
- GTM at-a-Glance - Middle East & Africa (MEA)
- GTM Readiness Radar – MEA
- Country Cluster Heatmap – MEA
- GTM Timeline – Pilot-to-Scale (2024-2029) - MEA
- Adjacency-Opportunity Radar - MEA
- GTM Maturity Highlights
- Regulatory Velocity - MEA
- Attach Rate Trends - MEA
- List of Figures
- Figure 1: Global AI-Imaging Revenue (2023-2032)
- Figure 2: Market Momentum Matrix (M3) by Modality Worldwide
- Figure 3: Top-Down Market Funnel
- Figure 4: Bottom-up Attach Rate Flow (CT/MRI Example)
- Figure 5: Evidence Confidence – Density vs Reliability
- Figure 6: Annual Imaging Procedure Volumes by Modality
- Figure 7: Market Drivers and Restraints
- Figure 8: Markintel M^3 Matrix (Market Momentum Matrix) Global
- Figure 9: Market Momentum by Modality (Global)
- Figure 10: Markintel Technology Evolution Matrix (TEM) by Region
- Figure 11: Markintel Technology Evolution Matrix (TEM) by Imaging Modality
- Figure 12: Markintel Technology Evolution Matrix (TEM) by Clinical Application
- Figure 13: Markintel TDIT (Technology Diffusion and Impact Timeline)
- Figure 14: Markintel Solution Adoption & Growth Matrix - Worldwide
- Figure 15: Marktintel ARC Index (Approvals, Reimbursement, Clinical Validation) by Use Case
- Figure 16: Marktintel ARC Index Score - Oncology & Sub-Areas
- Figure 17: Marktintel ARC Index Score - Neurology & Sub-Areas
- Figure 18: Marktintel ARC Index Score - Cardiology & Sub-Areas
- Figure 19: Marktintel ARC Index Score - Resp/Pulmonary & Sub-Areas
- Figure 20: Marktintel ARC Index Score - Orthopedics & Sub-Areas
- Figure 21: FDA Imaging-AI Clearances Heatmap, 2018 – 2025 YTD
- Figure 22: Reimbursement Timeline Snapshot by Region & Clinical Area (2020-2027)
- Figure 23: Markintel GTM Growth Maturity Matrix – World Market
- Figure 24: World Market for AI in Medical Imaging by Geographic Region (2023-2032, USD Million)
- Figure 25: Big-5 Geographic Regions CAGR Waterfall
- Figure 26: Markintel GTM Growth vs Maturity – Oncology Imaging AI Worldwide
- Figure 27: Oncology Imaging AI FDA Clearances by Qtr
- Figure 28: Modality-Reach Heatmap – Oncology Imaging AI 2024
- Figure 29: Markintel GTM Growth Maturity Framework – Cardiology Imaging AI Worldwide
- Figure 30: Regulatory Velocity – New Cardiology AI Imaging Clearances (Mar 2024 to June 2025)
- Figure 31: Modality-Reach Heatmap – Cardiology AI 2024
- Figure 32: Markintel GTM Growth Maturity Framework – Neurology Imaging AI Worldwide
- Figure 33: Regulatory Velocity – New Neuro-AI Clearances – Neurology AI Imaging (Mar ’24 – Jun ’25)100
- Figure 34: Modality Reach Heat-Map – Neurology AI 2024
- Figure 35: Markintel GTM Growth Maturity Framework – Respiratory Imaging AI – World
- Figure 36: Regulatory Velocity – New Respiratory-AI Clearances (Mar ’24 – Jun ’25)
- Figure 37: Modality Reach Heat-Map – Respiratory Imaging AI Worldwide - 2024
- Figure 38: Markintel GTM Growth Maturity Framework – Orthopedic/MSK Imaging AI - World
- Figure 39: Regulatory Velocity – Orthopedic (MSK) Imaging AI Worldwide - (Mar ’24 – Jun ’25)
- Figure 40: Modality Reach Heat-Map – Orthopedic (MSK) AI
- Figure 41: Revenue Breakdown — “Other” Clinical Areas Imaging AI Worldwide (2024)
- Figure 42: Reimbursement Readiness Heatmap - Other Clinical Areas
- Figure 43: Other Clinical Areas Imaging AI Depth vs Breadth by Clinical Area
- Figure 44: Regulatory Velocity – Other Clinical Areas Imaging AI (Mar ’24 – Jun ’25)
- Figure 45: Markintel GTM Growth and Maturity Matrix – CT Imaging AI – World
- Figure 46: Regulatory Velocity for CT Imaging AI by Clinical Area
- Figure 47: Regulatory Velocity for CT Imaging AI by Region
- Figure 48: CT-Attach Rate by Region (2024)
- Figure 49: CT AI Revenue Split (Factory vs Retrofit) by Region
- Figure 50: Markintel GTM Growth and Maturity Matrix – MRI Imaging AI – World
- Figure 51: Regulatory Velocity (MRI-AI Clearances) by Region
- Figure 52: Regulatory Velocity (MRI-AI Clearances) by Clinical Area
- Figure 53: MRI AI-Attach Rate by Region (2024)
- Figure 54: Factory vs Retrofit Revenue Split (MRI AI, 2024)
- Figure 55: Markintel GTM Growth and Maturity Matrix – X-ray Imaging AI – World
- Figure 56: Regulatory Velocity - X-ray AI by Region
- Figure 57: Regulatory Velocity - X-ray AI by Clinical Area
- Figure 58: Attach-Rate by Region (X-ray AI, 2024)
- Figure 59: Factory vs Retrofit Revenue Split (X-ray AI, 2024)
- Figure 60: Markintel GTM Growth and Maturity Matrix – Ultrasound AI - World
- Figure 61: Ultrasound AI Regulatory Velocity by Region
- Figure 62: Ultrasound AI Regulatory Velocity by Clinical Area
- Figure 63: Ultrasound AI Attach-Rate by Region (2024)
- Figure 64: Ultrasound A Factory vs Retrofit Revenue Split (2024)
- Figure 65: Markintel GTM Growth and Maturity Matrix – Nuclear/PET imaging AI – World
- Figure 66: Markintel GTM Growth and Maturity Matrix – North America
- Figure 67: Regulatory Velocity – North America
- Figure 68: OEM AI Attach-Rate by Modality - North America
- Figure 69: Factory vs Retrofit – North America
- Figure 70: Markintel Growth Maturity Matrix – US & Canada
- Figure 71: Markintel Solution Adoption & Growth Matrix – US & Canada
- Figure 72: Markintel Ecosystem Collaboration Matrix – US & Canada
- Figure 73: GTM Readiness Radar - US
- Figure 74: Customer Tier Potential - US
- Figure 75: GTM Timeline (2025–2028) - US
- Figure 76: Regulatory x Funding Heatmap – US (2024)
- Figure 77: Dual-Layer Adjacency-Opportunity Radar – US (Post-2026)
- Figure 78: Whitespace Partner-Fit Matrix - US (2024-26)
- Figure 79: GTM Readiness Radar - Canada
- Figure 80: Market Potential by Customer Tier - Canada (2032)
- Figure 81: Regulatory Velocity by Company – Europe
- Figure 82: Markintel Growth Maturity Matrix – Europe
- Figure 83: Markintel™ Ecosystem Collaboration Matrix (ECM) – Europe
- Figure 84: Markintel Solution Adoption & Growth Matrix – Europe
- Figure 85: OEM AI Attach Rate - Europe (2024)
- Figure 86: AI Revenue Split – Factory vs Retrofit Attach -- Europe (2024)
- Figure 87: GTM Readiness Radar — Europe
- Figure 88: Potential by Customer Tier - Europe (2032)
- Figure 89: GTM Timeline (2025 → 2028) - Europe
- Figure 90: Adjacency Opportunity Radar (2026+) – Europe
- Figure 91: Regulatory x Funding Heatmap – Europe (2024)
- Figure 92: AI Imaging Whitespace Matrix – Europe
- Figure 93: GTM Readiness Radar — Germany
- Figure 94: Projected Imaging AI Spend by Customer Tier - Germany (2032)
- Figure 95: GTM Timeline - Germany
- Figure 96: GTM Readiness Radar — What Counts Most in France
- Figure 97: GTM Timeline (2024 30) - France
- Figure 98: Spend Potential by Customer Tier – France (2032)
- Figure 99: GTM Readiness Radar – UK
- Figure 100: Spend Potential by Customer Tier - UK (2032)
- Figure 101: GTM Timeline (2024 29) - UK
- Figure 102: Tiered Customer Landscape & Spend Potential (2032)
- Figure 103: GTM Readiness Radar - Italy
- Figure 104: GTM Timeline (2024-29) – Italy
- Figure 105: GTM Readiness Radar – Spain
- Figure 106: Tiered Customer Landscape – Spain
- Figure 107: GTM Timeline – Spain (2024-2029)
- Figure 108: GTM at a Glance – Rest of Europe (ROE)
- Figure 109: Tiered Customer Landscape - ROE (2032)
- Figure 110: GTM Timeline - ROE
- Figure 111: Regulatory Funding Heatmap (ROE Clusters)
- Figure 112: Markintel GTM Growth and Maturity Matrix – APAC
- Figure 113: Regulatory Velocity - APAC
- Figure 114: OEM AI Attach Rate – APAC
- Figure 115: AI Revenue Split - Factory vs Retrofi t – APAC
- Figure 116: GTM Readiness Radar – APAC
- Figure 117: Tiered Customer Landscape – APAC (2032)
- Figure 118: GTM Timeline – APAC (2024-29)
- Figure 119: Regulatory Funding Heatmap – APAC
- Figure 120: Markintel Growth Maturity Matrix – China AI in Medical Imaging
- Figure 121: Markintel Ecosystem Collaboration Matrix – China
- Figure 122: Markintel Solution Adoption and Growth Matrix – China
- Figure 123: GTM Readiness Radar – China
- Figure 124: Tiered Customer Landscape – China (2032)
- Figure 125: GTM Timeline – China (2024-29)
- Figure 126: Adjacency-Opportunity Radar – China
- Figure 127: Regulatory Funding Heatmap – China
- Figure 128: Markintel Solution Adoption & Growth Matrix – Japan
- Figure 129: Markintel Ecosystem Collaboration Matrix – Japan
- Figure 130: GTM Readiness Radar – Japan
- Figure 131: GTM Timeline – Japan
- Figure 132: Adjacency Opportunity Radar – Japan
- Figure 133: Regulatory Funding Heatmap – Japan
- Figure 134: White Space Partnership Matrix – Japan
- Figure 135: Markintel Solution Adoption & Growth Matrix - India
- Figure 136: Markintel Ecosystem Collaboration Matrix – India
- Figure 137: GTM Readiness Radar – India
- Figure 138: Tiered Customer Landscape – India
- Figure 139: GTM Timeline – India
- Figure 140: Adjacency-Opportunity Radar – India
- Figure 141: Regulatory x Funding Heatmap – India
- Figure 142: Six-Pillar GTM Readiness Radar – South Korea
- Figure 143: Tiered Customer Landscape – South Korea
- Figure 144: Five-Step GTM Timeline – South Korea
- Figure 145: Adjacency-Opportunity Radar – South Korea
- Figure 146: Regulatory x Funding Heatmap – South Korea
- Figure 147: GTM Readiness Radar – Australia
- Figure 148: GTM Timeline – Australia
- Figure 149: Adjacency-Opportunity Radar – Australia
- Figure 150: Regulatory x Funding Heatmap
- Figure 151: GTM Readiness Heatmap – ROAPAC Clusters
- Figure 152: Five-Step GTM Roll Out Timeline (2024 2029) - ROAPAC
- Figure 153: Growth Driver Waterfall – LATAM
- Figure 154: Markintel Solution Adoption & Growth Matrix - LATAM
- Figure 155: Markintel Ecosystem Collaboration Matrix – LATAM
- Figure 156: GTM Readiness Radar – LATAM
- Figure 157: GTM Timeline – LATAM
- Figure 158: Cluster-Priority Heatmap
- Figure 159: Regulatory Velocity & Reimbursement Pulse – LATAM
- Figure 160: OEM AI Attach Rate – LATAM
- Figure 161: Markintel Solution Adoption & Growth Matrix – MEA
- Figure 162: Markintel Ecosystem Collaboration Matrix – MEA
- Figure 163: GTM Readiness Radar – MEA
- Figure 164: Country Cluster Heatmap – MEA
- Figure 165: GTM Timeline – Pilot to Scale (2024-2029) – MEA
- Figure 166: Adjacency-Opportunity Radar – MEA
- Figure 167: Regulatory Velocity - MEA
- Figure 168: Attach Rate Trends - MEA
- List of Tables
- Table 1: World Market for AI in Medical Imaging by Geographic Region (2023-2032, USD Million)
- Table 2: World Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
- Table 3: World Market for AI in Oncology Imaging by Region (2023-2032, USD Million)
- Table 4: World Market for AI in Cardiology Imaging by Region (2023-2032, USD Million)
- Table 5: World Market for AI in Neurology Imaging by Region (2023-2032, USD Million)
- Table 6: World Market for AI in Respiratory Imaging by Region (2023-2032, USD Million)
- Table 7: World Market for AI in Orthopedic/MSK Imaging by Region (2023-2032, USD Million)
- Table 8: World Market for AI in Imaging for Other Clinical Areas by Region (2023-2032, USD Million)..113
- Table 9: World Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
- Table 10: World Market for CT Modality AI (2023-2032, USD Million)
- Table 11: World Market for MRI Modality AI (2023-2032, USD Million)
- Table 12: World Market for X-ray Modality AI (2023-2032, USD Million)
- Table 13: World Market for Ultrasound Modality AI (2023-2032, USD Million)
- Table 14: World Market for Nuclear/PET Modality AI (2023-2032, USD Million)
- Table 15: World Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
- Table 16: World Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
- Table 17: World Market for AI in Medical Imaging by End-Use Org (2023-2032, USD Million)
- Table 18: World Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
- Table 19: AI Imaging Market by Country - North America (2023—2032, USD Mill)
- Table 20: US Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
- Table 21: US Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
- Table 22: US Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
- Table 23: US Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
- Table 24: US Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
- Table 25: US Market for AI in Medical Imaging by AI Technology (2023-2032, USD Mill)
- Table 26: Canadian Market by Clinical Area (2023-2032, USD Million)
- Table 27: Canadian Market by Imaging Modality (2023-2032, USD Million)
- Table 28: Canadian Market by Revenue Stream (2023-2032, USD Million)
- Table 29: Canadian Market by Clinical Application (2023-2032, USD Million)
- Table 30: Canadian Market by End-Use Organization (2023-2032, USD Million)
- Table 31: Canadian Market by AI Technology (2023-2032, USD Million)
- Table 32: AI Imaging Market by Country - Europe (2023—2032, USD Mill)
- Table 33: German Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
- Table 34: German Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
- Table 35: German Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
- Table 36: German Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)..234
- Table 37: German Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
- Table 38: German Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
- Table 39: French Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
- Table 40: French Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
- Table 41: French Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
- Table 42: French Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
- Table 43: French Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)245
- Table 44: French Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
- Table 45: UK Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
- Table 46: UK Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
- Table 47: UK Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
- Table 48: UK Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
- Table 49: UK Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
- Table 50: UK Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
- Table 51: Italian Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
- Table 52: Italian Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
- Table 53: Italian Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
- Table 54: Italian Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
- Table 55: Italian Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million) 260
- Table 56: Italian Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
- Table 57: GTM Readiness Radar - Italy
- Table 58: Spanish Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
- Table 59: Spanish Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
- Table 60: Spanish Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)..266
- Table 61: Spanish Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
- Table 62: Spanish Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
- Table 63: Spanish Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
- Table 64: Rest of Europe Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)..271
- Table 65: Rest of Europe Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
- Table 66: Rest of Europe Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
- Table 67: Rest of Europe Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
- Table 68: Rest of Europe Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
- Table 69: Rest of Europe Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
- Table 70: Adjacency-Opportunity Matrix - ROE (2026-2030)
- Table 71: White-Space Partnership Matrix - ROE
- Table 72: AI Imaging Market by Country - APAC (2023—2032, USD Mill)
- Table 73: Adjacency Opportunity Matrix - APACAdjacency Opportunity Matrix - APAC
- Table 74: Country-Cluster Framework - APAC
- Table 75: White Space Partner Framework – APAC
- Table 76: Channel x Pricing Matrix – APAC
- Table 77: Chinese Market by Clinical Area (2023-2032, USD Million)
- Table 78: Chinese Market by Modality (2023-2032, USD Million)
- Table 79: Chinese Market by Revenue Stream (2023-2032, USD Million)
- Table 80: Chinese Market by Clinical Application (2023-2032, USD Million)
- Table 81; Chinese Market by End-Use Organization (2023-2032, USD Million)
- Table 82: Chinese Market by AI Technology (2023-2032, USD Million)
- Table 83: Japanese Market by Clinical Area (2023-2032, USD Million)
- Table 84: Japanese Market by Modality (2023-2032, USD Million)
- Table 85: Japanese Market by Revenue Stream (2023-2032, USD Million)
- Table 86: Japanese Market by Clinical Application (2023-2032, USD Million)
- Table 87: Japanese Market by End-Use Organization (2023-2032, USD Million)
- Table 88: Japanese Market by AI Technology (2023-2032, USD Million)
- Table 89: Indian Market by Clinical Area (2023-2032, USD Million)
- Table 90: Indian Market by Modality (2023-2032, USD Million)
- Table 91: Indian Market by Revenue Stream (2023-2032, USD Million)
- Table 92: Indian Market by Clinical Application (2023-2032, USD Million)
- Table 93: Indian Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million) 323
- Table 94: Indian Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
- Table 95: South Korean Market by Clinical Area (2023-2032, USD Million)
- Table 96: South Korean Market by Modality (2023-2032, USD Million)
- Table 97: South Korean Market by Revenue Stream (2023-2032, USD Million)
- Table 98: South Korean Market by Clinical Application (2023-2032, USD Million)
- Table 99: South Korean Market End-Use Organization Type (2023-2032, USD Million)
- Table 100: South Korean Market by AI Technology (2023-2032, USD Million)
- Table 101: Australian Market by Clinical Area (2023-2032, USD Million)
- Table 102: Australian Market by Modality (2023-2032, USD Million)
- Table 103: Australian Market by Revenue Stream (2023-2032, USD Million)
- Table 104:Australian Market by Clinical Application (2023-2032, USD Million)
- Table 105: Australian Market by End-Use Organization (2023-2032, USD Million)
- Table 106: Australian Market by AI Technology (2023-2032, USD Million)
- Table 107: Rest of Asia-Pacific (ROAPAC) Market by Clinical Area (2023-2032, USD Million)
- Table 108: Rest of Asia-Pacific (ROAPAC) Market by Modality (2023-2032, USD Million)
- Table 109: Rest of Asia-Pacific (ROAPAC) Market by Revenue Stream (2023-2032, USD Million)
- Table 110: Rest of Asia-Pacific (ROAPAC) Market by Clinical Application (2023-2032, USD Million)
- Table 111: Rest of Asia-Pacific (ROAPAC) Market by End-Use Organization (2023-2032, USD Million) ..356
- Table 112: Rest of Asia-Pacific (ROAPAC) Market by AI Technology (2023-2032, USD Million)
- Table 113: Latin American (LATAM) Market by Clinical Area (2023-2032, USD Million)
- Table 114: Latin American (LATAM) Market by Modality (2023-2032, USD Million)
- Table 115: Latin American (LATAM) Market by Revenue Stream (2023-2032, USD Million)
- Table 116: Latin American (LATAM) Market by Clinical Application (2023-2032, USD Million)
- Table 117: Latin American (LATAM) Market by End-Use Organization (2023-2032, USD Million)
- Table 118: Latin American (LATAM) Market by AI Technology (2023-2032, USD Million)
- Table 119: Middle East and African (MEA) Market by Clinical Area (2023-2032, USD Million)
- Table 120: Middle East and African (MEA) Market by Modality (2023-2032, USD Million)
- Table 121: Middle East and African (MEA) Market by Revenue Stream (2023-2032, USD Million)
- Table 122: Middle East and African (MEA) Market by Clinical Application (2023-2032, USD Million)
- Table 123: Middle East and African (MEA) Market by End-Use Organization (2023-2032, USD Million) 376
- Table 124: Middle East (MEA) Market AI Technology (2023-2032, USD Million)
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.